SunTrust Robinson Humphrey Initiates Coverage On Regeneron Pharmaceuticals with Hold Rating, Announces $360 Price Target

SunTrust Robinson Humphrey initiates coverage on Regeneron Pharmaceuticals (NASDAQ:REGN) with a Hold rating and a $360 price target.

Benzinga · 11/12/2019 11:35

SunTrust Robinson Humphrey initiates coverage on Regeneron Pharmaceuticals (NASDAQ:REGN) with a Hold rating and a $360 price target.